Causaly secures $60 Million in series B funding
Causaly, a company that uses AI for biomedical research, has closed a $60m Series B round led by ICONIQ Growth,…
All articles by Michelle Moore
Michelle Moore
Michelle Moore joined Medical Device Network in 2023 as a trainee healthcare reporter. With a background in medical science and economics, Michelle has experience working on medical and socioeconomic research projects. She is interested in molecular biology, personalised medicine and how artificial intelligence is changing the face of healthcare. Michelle holds a BSc in Biomedical Science and an MSc in Molecular Medicine, both from the University of Sheffield, as well as an MSc(Res) in Medicine and Economics from the University of St Andrews.
-
-
Skyelarke makes public significant changes to SkyePay
Skyelarke, the health technology company specialising in making clinical research accessible, has announced alterations to its patient payment technology SkyePay.…
-
Labcorp forms spin-off of Fortrea
Labcorp, the laboratory service supplier based in the US, has completed the spin-off of Fortrea, to create the newly formed…
-
Camena bags $10m in funding from Mercia
Camena Bioscience, a synthetic biology company that provides genes to pharmaceutical and biotechnology industries, has closed a $10m Series A…